Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma

EXCLI Journal

Volumn 12, Issue , 2013, Pages 184-192

  Eftekhari, Parivash ^a   Hajizadeh, Sohrab ^a   Reza Raoufy, Mohammad ^a   Reza Masjedi, Mohammad ^b   Yang, Ming ^c   Hansbro, Nicole ^c   Li, Jing Jing ^c   Foster, Paul S ^c,d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d Australian National University   (Australia)

Author keywords

Acute exacerbation; Eosinophil; N acetylcysteine; Neutrophil; Steroid resistant asthma

Indexed keywords

ACETYLCYSTEINE; GLUCOCORTICOID; INTERLEUKIN 13; INTERLEUKIN 5; STEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; EOSINOPHIL COUNT; HORMONE SENSITIVITY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; RESPIRATORY TRACT ALLERGY;

EID: 84875088304     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aliyali M, Poorhasan Amiri A, Sharifpoor A, Zalli F. Effects of N-acetylcysteine on asthma exacerbation. Iran J Allergy Asthma Immunol 2010;9:103-9.
2. Barnes PJ. Corticosteroid resistance in airway diseases. Proc Am Thorac Soc 2004;1: 264-8.
3. Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010;120:76-85.
4. Bengtsson A, Lundberg M, Avila-Cariño J, Jacobsson G, Holmgren A, Scheynius A. Thiols decrease cytokine levels and downregulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. Clin Exp Immunol 2001;123:350-60.
5. Bernareggi M, Radice S, Rossoni G, Oriani G, Chiesara E, Berti F. Hyperbaric oxygen increases plasma exudation in rat trachea: involvement of nitric oxide. Br J Pharmacol 1999;126:794-800.
6. Blesa S, Cortijo J, Martinez-Losa M, Mata M, Seda E, Santangelo F et al. Effectiveness of oral N-acetylcysteine in a rat experimental model of asthma. Pharmacol Res 2002;45:135-40.
7. Bloom JW, Chacko J, Lohman IC, Halonen M, Martinez FD, Miesfeld RL. Differential control of eosinophil survival by glucocorticoids. Apoptosis 2004;9:97-104.
8. Cai S, Chen P, Zhang C, Chen JB, Wu J. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats. Respirology 2009;14:354-9.
9. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008;31:1334-56.
10. Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol 2008;122: 456-68.
11. Corren J. Inhibition of interleukin-5 for the treatment of eosinophilic diseases. Discov Med 2012;13:305-12.
12. Cortijo J, Cerdá-Nicolás M, Serrano A, Bioque G, Estrela JM, Santangelo F et al. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J 2001;17:1228-35.
13. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 2002;109: 649-57.
14. Ito K, Herbert C, Siegle JS, Vuppusetty C, Hansbro N, Thomas PS et al. Steroidresistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am J Respir Cell Mol Biol 2008; 39:543-50.
15. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006;111: 476-94.
16. Larché M. Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol 2006;18:745-50.
17. Leff JA, Wilke CP, Hybertson BM, Shanley PF, Beehler CJ, Repine JE. Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats. Am J Physiol Lung Cell Mol Physiol 1993;265: L501-6.
18. Li JJ, Wang W, Baines KJ, Bowden NA, Hansbro PM, Gibson PG et al. IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J Immunol 2010;185:4401-9.
19. Liang RY, Wu W, Huang J, Jiang SP, Lin Y. Magnesium affects the cytokine secretion of CD4(+) T lymphocytes in acute asthma. J Asthma 2012 Nov 8; epub ahead of print.
20. Martinez-Losa M, Cortijo J, Juan G, O'Connor JE, Sanz MJ, Santangelo F et al. Inhibitory effects of N-acetylcysteine on the functional responses of human eosinophils in vitro. Clin Exp Allergy 2007;37:714-22.
21. Marwick JA, Caramori G, Stevenson CS, Casolari P, Jazrawi E, Barnes PJ et al. Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med 2009;179:542-8.
22. Marwick JA, Adcock IM, Chung KF. Overcoming reduced glucocorticoid sensitivity in airway disease molecular mechanisms and therapeutic approaches. Drugs 2010;70: 929-48.
23. Máximo Cardoso L, de Almeida Colombari DS, Vanderlei Menani J, Alves Chianca D Jr, Colombari E. Cardiovascular responses produced by central injection of hydrogen peroxide in conscious rats. Brain Res Bull 2006;71:37-44.
24. Shannon J, Ernst P, Yamauchi Y, Olivenstein R, Lemiere C, Foley S et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008;133:420-6.
25. Song DJ, Min MG, Miller M, Cho JY, Broide DH. Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen. Am J Physiol Lung Cell Mol Physiol 2009:297:L380-7.
26. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM. Nacetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells. Eur Respir J 2003;22:43-9.